MENU
+Compare
XRAY
Stock ticker: NASDAQ
AS OF
Apr 3, 04:59 PM (EDT)
Price
$13.61
Change
-$1.26 (-8.47%)
Capitalization
6.69B

XRAY DENTSPLY SIRONA Forecast, Technical & Fundamental Analysis

Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies... Show more

XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XRAY with price predictions
Apr 02, 2025

XRAY's RSI Oscillator climbs out of oversold territory

The RSI Indicator for XRAY moved out of oversold territory on April 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for XRAY just turned positive on March 20, 2025. Looking at past instances where XRAY's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XRAY advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

XRAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XRAY as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XRAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XRAY entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.032) is normal, around the industry mean (23.715). P/E Ratio (19.231) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (1.574) is also within normal values, averaging (5.667). Dividend Yield (0.018) settles around the average of (0.018) among similar stocks. P/S Ratio (1.725) is also within normal values, averaging (41.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. XRAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XRAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XRAY is expected to report earnings to fall 31.00% to 30 cents per share on May 01

DENTSPLY SIRONA XRAY Stock Earnings Reports
Q1'25
Est.
$0.30
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Est.
$0.42
The last earnings report on February 27 showed earnings per share of 43 cents, beating the estimate of 43 cents. With 1.35M shares outstanding, the current market capitalization sits at 6.69B.
A.I.Advisor
published Dividends

XRAY is expected to pay dividends on April 11, 2025

DENTSPLY SIRONA XRAY Stock Dividends
A dividend of $0.16 per share will be paid with a record date of April 11, 2025, and an ex-dividend date of March 28, 2025. The last dividend of $0.16 was paid on January 10. Read more...
A.I. Advisor
published General Information

General Information

a global denal eqipment company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13320 Ballantyne Corporate Place
Phone
+1 844 848-0137
Employees
15000
Web
https://www.dentsplysirona.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TPOR24.741.12
+4.74%
Direxion Dly Transp Bull 3X Shrs ETF
SBIO27.780.78
+2.89%
ALPS Medical Breakthroughs ETF
FEZ54.910.29
+0.53%
SPDR® EURO STOXX 50 ETF
NBCM22.870.11
+0.48%
Neuberger Berman Commodity Stgy ETF
JHMD35.060.04
+0.11%
JHancock Multifactor Developed Intl ETF

XRAY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+1.50%
NVST - XRAY
42%
Loosely correlated
+2.40%
STE - XRAY
41%
Loosely correlated
+0.82%
HBIO - XRAY
40%
Loosely correlated
-0.31%
LH - XRAY
40%
Loosely correlated
+1.60%
KIDS - XRAY
39%
Loosely correlated
+5.03%
More